🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Efficacy and Safety from a high-dosed subcutaneous recombinant preparation...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2008-03
Trial ID
NCT00671268
The study will evaluate the efficacy and safety of BM32 in grass pollen all...
Status
Completed
Location
Medical University
Start Date
2012-03
Trial ID
NCT01538979
The study will evaluate the dose response of immunotherapy against grass po...
Status
Completed
Location
Allergy Center Vienna West
Start Date
2011-10
Trial ID
NCT01445002
The aim of the present skin test study CS-BM32-001 is to evaluate whether t...
Status
Completed
Location
Medical University
Start Date
2011-05
Trial ID
NCT01350635
Treatments Being Tested
Dose-response trial with a cocktail of recombinant major allergens of Timot...
Status
Completed
Location
Prof. Dr. med. Ludger Klimek
Start Date
2007-09
Trial ID
NCT00666341
The trial is performed to assess efficacy and safety of a recombinant grass...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2004-01
Trial ID
NCT00309036
Treatments Being Tested
To evaluate efficacy and tolerability of specific subcutaneous immunotherap...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2009-10
Trial ID
NCT01353755
Treatments Being Tested